Sat, Jan 31, 2015, 3:47 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

mclim73 37 posts  |  Last Activity: 8 hours ago Member since: Apr 11, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    THLD Presents Encouraging PII Myeloma Data at ASH

    by dmj3430 Dec 6, 2014 2:37 PM
    mclim73 mclim73 Dec 7, 2014 11:06 AM Flag

    it just adds the the body of evidence for TH-302. over 1500 patients treated. Like Dawg said (where is he recently?) its not matter of if TH-302 works, but rather how well.

    Cheers, this will be double digits in 1 year. There is NO way this stay below $10 on the heals of TWO phase III trials data release in 14 moths.

  • in hypoxic area of the cancer on the slides presented couple days ago. I always wondered why there was no proof of this and bam! Double digits before BOTH pc and STS results come out, and 50s if both succeed.
    50s means 3.5B market cap, which is a NO Brainer if both make it. Add lung and brain possibilities, and 100s isn't too far fetched. Not pumping just demonstrating what this stock can do if successful.

    Hold for just 1.2 years and you'll be glad u did.

    GL all.

  • getting noticed more and more. double digits by end of 2015, and teens w/ mom right b4 STS and PC data release.

  • Very very convincing call. TH-302 on STS, PC, Brain, etc.
    CEO very happy that there will be two Phase III data out for very early 2016. He said very early 2016 which probably means January.

    I know its hard to believe we are in the high 2s to low 3s right now.
    I will guarantee that this will catch mom towards mid to end of 2015 and hit double digits VERY easily.

    I wouldn't be shocked to see this in the teens right before data, especially w/ multiple ariticles out by Adam you know who, and bunch of Seeking Alpha articles along w/ JPM conferences coming on on January etc.

    Easiest triple i've seen in a while. Buy all now, sell half at teens, hold rest for possible homerun to the 50s if both data is good.

    oh also, brain cancer can get fast tracked easily as well.

    this is no brainer of all no brainers imo.

    Sentiment: Strong Buy

  • Reply to

    Only question i have is:

    by mclim73 Nov 11, 2014 12:15 PM
    mclim73 mclim73 Nov 11, 2014 1:12 PM Flag

    As you know, there was interim look on STS trial. Although company and public is blinded to the data, perhaps FDA can have a look for whatever reason, such as safety reason etc. They saw that data was close to hitting the 45% threshold and said, man we better rush this thing.

    just wondering, nothing else.

  • Reply to

    First time we have proof TH-302 reduces burden

    by mclim73 Nov 19, 2014 12:29 PM
    mclim73 mclim73 Nov 20, 2014 10:42 AM Flag

    unlike you, i realize that there is a huge catalyst in first quarter 2016. I will ride it and make money. This will be double digits before the results.. triple is a good thing w/in a year.

    as for the trials.. i suspect STS is a roll of a dice. However w/ PC, with a good phase 2 trial, i give PC Phase 3 trial chances to be in the 90% chance. Im holding at least half.

    we only need 1.5 month improvement in PC trials to meet the SPA requirements. Seems easy enough.

    Thanks for reminder of the managment's dozen years... broken clock is right two times a day. Lets hope this is one of them for this management.


  • Reply to

    JP morgan 5%+ ownerership?

    by mclim73 Dec 10, 2014 11:21 AM
    mclim73 mclim73 Dec 10, 2014 11:22 AM Flag

    easiest money avaialble for 2015.. not kidding.

  • Reply to

    Change of Control Severance Agreements.....

    by tredleon Jan 7, 2015 6:06 PM
    mclim73 mclim73 Jan 7, 2015 8:57 PM Flag

    Agreed. Seems somethings in the works...hence the recent rise. What I can see is that we can get warrants for future success of th302 if we were to get offers. 10 bucks buyout with 10buck warrant for sts and pc... another 10 for lungs etc.

  • may THLD be double digits this year and over $50 the year after!

  • mclim73 by mclim73 Nov 11, 2014 7:47 PM Flag

    Phase III STS fully enrolled and Data out 1st Q 2016.
    Phase III Pancreatic Cancer fully enrolled and data out sometimes also in 2016.
    Phase II trial Lung Cancer enrolling 400+ people currently, which if good can skip Phase III.
    SPA, Orphan Status, Fast Track.

    Just Buy at hold at these rediculous prices. If any one of the three succeed. we are looking at mulit mulit baggers in just a little bit over 1 year. Long many many shares avg now at 3.50.

  • Reply to


    by rlrgrs65 Nov 5, 2014 11:21 AM
    mclim73 mclim73 Nov 5, 2014 4:21 PM Flag

    Two phase 3 trials not due until 2016... catalyst too far away. That said, this will climb back up early next year to mid 3s to low 4s.. then hover then shoot up to 7s by last 2015, and into the teens right b4 P3 STS results are out.

    Excellent time to buy and hold for multi bagger in 1.5 years.

  • Reply to

    JP morgan 5%+ ownerership?

    by mclim73 Dec 10, 2014 11:21 AM
    mclim73 mclim73 Dec 10, 2014 11:21 AM Flag

    teens w/ momo.. argh.. good morning all lol.

  • Reply to


    by uyene Nov 25, 2014 12:01 PM
    mclim73 mclim73 Nov 25, 2014 5:30 PM Flag

    do you think this will be at 2s and 3s right before the results of STS and PC is out? honestly.. i expect a triple from here by end of next year. 1 year for triple. just buy and hold.

  • Reply to

    $5 by ASCO and $7 summer

    by mclim73 Jan 22, 2015 8:07 PM
    mclim73 mclim73 Jan 22, 2015 11:12 PM Flag

    yea it does seem unfathomable right? with TWO phase III trials coming very very early 2016, i expect nothing less. STS marktet is 500m w/ no drug approved in last 30 year, Pancreatic cancer, we need 2.1 months to say we are better than Abraxane. very doable. Oh yea.. proababably 1B+ for PC at least. OH did i meantion brain cancer and lung cancer? Lung trial will finish recruiting by end of the year as well, for another huge potential. But then again, im sure everyone knows it by the way this is at $3+ lol.

    word will get around towards mid/ end of the year as the catalyst gets closer and closer.

  • Then all break loose and double digits to $13s right b4 the results. $$$$$$$$$$.
    Wait is worth it.. trust me.

  • i even miss Beach lol.
    where is tred? dawg? other oldies that used to post regularly? Am i the last one standing? this will be very fun end of the year. will be double digits. how can it not be?

    You have STS Phase III and pancreatic cancer phase III coming out around the same time in early 1st Q 2016 (CEO's word).

    STS.. there is zero competing trials anywhere right now.
    Pancreatic.. you have Halo, but they only are targeted to a third of market and years away. we have very good chance of beating abraxane of 2 month and continue with combo trials.
    we have brain data which is very good.. expect to see some good data on this as well toward end of 2015.

    all this forrrrrrrrrrrrrrrrrr: $3 and change lol. less than 300m market cap.

    dare i say triple by end of the year? im holding this gem and selling half at double digits to lock in gains and let it ride for the data.

    Merck will spend over 1/2 billion on this alone. They can easily buy this as well.
    It not question of if this works or not, but how well.

    gl all.

  • Reply to


    by biomaniac007 Jan 20, 2015 11:20 AM
    mclim73 mclim73 Jan 20, 2015 12:36 PM Flag

    what notes?

  • Does FDA make decision based on interim data that was not available to the company or public?

  • Reply to

    Let's Face It

    by truthseekers100 Nov 5, 2014 9:50 PM
    mclim73 mclim73 Nov 6, 2014 2:25 PM Flag

    i agree... this is totally out of flavor for now.
    HGSI, DNDN, MNKD were all in the 1s to 3 for longggggggg time.. even right b4 the p3 results... of course they all were multi baggers.

    I think THLD will hover 3 to 5 for a while.. then one day, momo will hit and take this to the teens right before STS results. at that time, this will be pumped as the next 100 bagger. Just hold and be patient.

    What 160m market cap has finsihed enrolling for not one, but two major phase III trial and awaiting results? Don't forget there is another large P2 trial in lung cancer too.

    If any 1 of them succeed, this will be mulit mulit bagger.
    Im very sure TH302 works.. it is just how well.
    the Phase II trial in PC was very convincing and i give P3 succeeding a very good chance.
    STS.. i think will be 50/50 shot. PC is the main reason im here. proably 1.5 years away from seeing PC results.


  • Reply to

    What Fast-Track Means

    by beameup_999 Nov 13, 2014 1:12 PM
    mclim73 mclim73 Nov 13, 2014 4:07 PM Flag

    you know im a long term holder... this news doesn't mean that much to be honest. Either P3 trial will suceed or it won't... simple as that.

    Im leaning 50/50 on STS and 80/20 yes on Pancreatic. Late 2015/ early 2016 will be fun for sure.

93.600.00(0.00%)Aug 14 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.